
    
      This is a clinical evaluation of the XIENCE V® everolimus eluting coronary stent system as a
      revascularization treatment of patients with multi-vessel coronary artery disease (MVD-CAD).

      The sutdy is composed of two parts:

      A Randomized Controlled Trial, outlined in a separate posting and the registry portion of
      this study, which is as follows:

      -A prospective controlled registry to analyze the clinical efficacy and safety at mid and
      long-term follow-up in patients with MVD treated with the XIENCE V® Everolimus Eluting
      Coronary Stent System (XIENCE V® EECSS).
    
  